Baystreet Staff -

These Marijuana Stocks Are Hitting New Highs This Week

[ACCESSWIRE]

CORAL GABLES, FL / ACCESSWIRE / December 11, 2018 / The cannabis industry continues to expand on a global scale. Where last year, investors could only dream of what was to come, today we're now seeing multi-billion dollar industry investments and even bigger buyouts abroad. Just recently some of the leading marijuana companies have made a push to conduct mergers and acquisitions outside of North America. The global legal marijuana market is expected to reach USD $146.4 billion by end of 2025, according to a new report by Grand View Research, Inc. citing growing adoption of marijuana in several medical applications.

Premier Health Group (OTC: PHGRF) (CSE: PHGI), New Age Beverages (NASDAQ: NBEV), Aphria (NYSE: APHA; TSX: APHA), and Tilray (TLRY) are four cannabis stocks to watch this month.

After Premier Health Group (OTC: PHGRF) (CSE: PHGI) recently engaged in discussions with Licensed Producers under the Access to Cannabis for Medical Purposes Regulation, the company is looking to establish a framework for entry into the cannabis arena. The company announced this week that as a part of its growth strategy to cover the major verticals associated with primary care, it has signed a binding Letter of Intent to acquire a Vancouver, British Columbia based pharmacy. Premier Health Group (OTC: PHGRF) (CSE: PHGI) said that it expects the acquisition to close in or about Q1-19.

This move could prove to be an exciting one for Premier Health Group (OTC: PHGRF) (CSE: PHGI). The Canadian medical cannabis clinic market is estimated to be worth approximately $2.35 billion by 2025. Furthermore, many Canadian pharmacies are making a push to become outlets for medical cannabis sales. With this in mind, the company said that it expects to provide additional updates on further acquisitions in Q4-18 and Q1-19.

''We are excited for this opportunity to acquire our first pharmacy, and thereafter being able to prepare and deliver prescription and non-prescription pharmaceuticals and other health products to patients. In doing so, the pharmacist will play an integral role in our team-based patient-centric model,'' said Dr. Essam Hamza, CEO of Premier Health Group.

Premier Health Group (OTC: PHGRF) (CSE: PHGI) subsidiary, HealthVue is focused on developing proprietary technology to deliver quality healthcare through the combination of connected primary care clinics with telemedicine and artificial intelligence. The company currently has an ecosystem of over 100,000 active patients and has plans to rapidly increase that number both domestically and internationally. To put it into perspective, Canopy Growth reported 84,400 registered patients at September 30, 2016. Furthermore, in its latest financial report, Aurora Cannabis for example, reported that it had 67,484 active registered patients and this was up from roughly 43,000 during the prior quarter.

For More Information On Premier Health Group, Click Here

Aphria (APHA) saw an active premarket session on Tuesday. Though shares closed on Monday at $5.61, Aphria's price jumped as high as $5.95 during early morning trading. The company completed its LATAM acquisition of LATAM Holdings Inc. This acquisition consisted of licenses and other assets and related businesses in Colombia, Argentina and Jamaica and a right of first offer and refusal in respect of Brazil.

Though the company came under scrutiny regarding this transaction, Aphria's management continues to stand behind the transaction.

Vic Neufeld, Aphria's Chief Executive Officer, said, "Since closing this important strategic acquisition in September, we have made considerable progress supporting and building out our operations on the ground in Latin America and the Caribbean. We have nearly 100 employees across the region dedicated to advancing the Company's business interests, including cultivation, processing, research and development, partnerships and continued expansion. International operations are a core component to our proven growth strategy and we are working to integrate and enhance operations and product channels throughout Latin America to position them for sustainable, long-term shareholder value creation."

For More Information On Aphria, Click Here

New Age Beverages (NBEV) shares jumped for a second day in a row, during premarket trading on Tuesday. The stock hit lows of $4.70 on Monday but reached highs of $5.24 before the opening bell on Tuesday. Like other cannabis companies, New Age is focusing on mergers and acquisitions.

Most recently the company announced the signing of a definitive agreement to acquire Morinda Holdings, Inc., a Utah-based healthy lifestyles and beverage company with operations in more than 60 countries around the world.

According to New Age, this combination brings a leading portfolio of healthy beverages, with multi-channel penetration spanning traditional retail, e-commerce, and in-home; with a hybrid route-to-market spanning direct-store-delivery, wholesale, and direct-to-consumer

Kerry Asay, CEO of Morinda commented, "We are so excited to be combining with New Age. When we envisioned what we could achieve with New Age's portfolio through our system, we knew how transformative it could be for all our employees and independent distributors around the world.''

For More Information On New Age Beverage, Click Here

Tilray (TLRY) may have helped bring more attention to the cannabis arena this year after reaching highs of $300 per share. Since then, however, the company's stock price has pulled back as low as $84.28. Outside of its share price, the company continues to focus on its business.

Inner Spirit Holdings Ltd. (CSE: ISH) announced this week that it has closed the first tranche of its previously announced investment agreement with Tilray, Inc. and its wholly-owned subsidiary High Park Holdings Ltd.

According to a corporate press release, this is the first tranche of a total investment of $4.5 million by Tilray into Inner Spirit. Pursuant to the terms of the Investment Agreement, on the third business day following the date which is six months after closing of the first tranche, subject to certain conditions in favor of each party, Tilray and Inner Spirit will exchange common shares valued at an additional $2.25 million based on the 10 day volume-weighted average price of each company's shares at the time of issuance.

As of Tuesday morning, shares of Tilray have already traded at highs of $99.45

For More Information On Tilray, Click Here

About marijuanastocks.com

MarijuanaStocks.com is the leading web destination for all things cannabis. Investors can find marijuana-related financial, medical, legal, and social news anytime day or night. Writers are invited to submit cannabis related articles for publication.

Legal Disclaimer

Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. MAPH Enterprises LLC which owns www.MarijuanaStocks.com is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release.

MAPH Enterprises LLC, which owns www.MarijuanaStocks.com, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. MAPH Enterprises LLC, which owns www.MarijuanaStocks.com, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC (owners of MarijuanaStocks.com), MIDAM VENTURES, LLC and Premier Health Group Inc., Midam was hired for a period from 10/1/2018 – 4/1/2019 to publicly disseminate information about Premier Health Group Inc. including on the Website and other media including Facebook and Twitter. Midam was paid $100,000 (CASH) for & were paid ''500,000'' shares of restricted common shares. We own zero shares of Premier Health Group Inc., which we purchased in the open market. Once the (6) Six-month restriction is complete on 4/1/2019 Midam plans to sell the ''500,000'' shares of Premier Health Group Inc. that Midam holds currently in restricted form during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of Premier Health Group Inc. in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Click here for our full disclaimer.

Contact Information:

[email protected]

SOURCE: MarijuanaStocks.com